Multipoint targeting of the PI3K/mTOR pathway in mesothelioma

被引：0
|
作者：
S Zhou
L Liu
H Li
G Eilers
Y Kuang
S Shi
Z Yan
X Li
J M Corson
F Meng
H Zhou
Q Sheng
J A Fletcher
W-B Ou
机构：
[1] Zhejiang Provincial Key Laboratory of Applied Enzymology,Department of Biotechnology and Biomedicine
[2] Yangtze Delta Region Institute of Tsinghua University,Department of Bioengineering
[3] College of Biology and Chemical Engineering,Department of Pathology
[4] Jiaxing University,Department of Biochemistry and Molecular Biology
[5] Brigham and Women’s Hospital and Harvard Medical School,undefined
[6] College of Life Sciences,undefined
[7] Zhejiang Sci-Tech University,undefined
来源：
British Journal of Cancer | 2014年 / 110卷
关键词：
mesothelioma; tyrosine kinases; PI3K/AKT/mTOR; PI3K/AKT/MDM2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2479 / 2488
页数：9
相关论文
共 50 条
  • [41] Targeting PI3K/mTOR signaling in cutaneous angiosarcoma
    Wada, M.
    Horinaka, M.
    Sakai, T.
    Masuzawa, M.
    Katoh, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S56 - S56
  • [42] Targeting PI3K/Akt/mTOR signaling in cancer
    Porta, Camillo
    Paglino, Chiara
    Mosca, Alessandra
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [43] DUAL TARGETING OF PI3K AND mTOR SIGNALING IN MEDULLOBLASTOMA
    Clymer, Jessica
    Eckerdt, Frank
    Bell, Jonathan
    Lulla, Rishi
    Goldman, Stewart
    Platanias, Leonidas
    NEURO-ONCOLOGY, 2016, 18 : 112 - 112
  • [44] Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast Cancer
    Sara E. Nunnery
    Ingrid A. Mayer
    Drugs, 2020, 80 : 1685 - 1697
  • [45] Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast Cancer
    Nunnery, Sara E.
    Mayer, Ingrid A.
    DRUGS, 2020, 80 (16) : 1685 - 1697
  • [46] Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer
    Fumarola, Claudia
    Bonelli, Mara A.
    Petronini, Pier Giorgio
    Alfieri, Roberta R.
    BIOCHEMICAL PHARMACOLOGY, 2014, 90 (03) : 197 - 207
  • [47] Melatonin effect on breast and ovarian cancers by targeting the PI3K/Akt/mTOR pathway
    Pourbarkhordar, Vahid
    Rahmani, Sohrab
    Roohbakhsh, Ali
    Hayes, A. Wallace
    Karimi, Gholamreza
    IUBMB LIFE, 2024, 76 (12) : 1035 - 1049
  • [48] Targeting the PI3K/mTOR pathway in idiopathic pulmonary fibrosis: Advances and therapeutic potential
    Wang, Zhengyang
    Guo, Yanzhi
    Li, Kaiyin
    Huo, Yan
    Wang, Shuyan
    Dong, Suzhen
    Ma, Mingliang
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 115
  • [49] Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer
    Bitting, Rhonda L.
    Armstrong, Andrew J.
    ENDOCRINE-RELATED CANCER, 2013, 20 (03) : R83 - R99
  • [50] Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
    Garg, Pankaj
    Ramisetty, Sravani
    Nair, Meera
    Kulkarni, Prakash
    Horne, David
    Salgia, Ravi
    Singhal, Sharad S.
    BIOCHEMICAL PHARMACOLOGY, 2025, 236
12345